Order Article Reprints

Al-Rawashde FA, Al-Sanabra OM, Alqaraleh M, Jaradat AQ, Al-Wajeeh AS, Johan MF, Wan Taib WR, Ismail I, Al-Jamal HAN. Thymoquinone Enhances Apoptosis of K562 Chronic Myeloid Leukemia Cells through Hypomethylation of SHP-1 and Inhibition of JAK/STAT Signaling Pathway. Pharmaceuticals. 2023; 16(6):884. https://doi.org/10.3390/ph16060884

Al-Rawashde, Futoon Abedrabbu, Ola M. Al-Sanabra, Moath Alqaraleh, Ahmad Q. Jaradat, Abdullah Saleh Al-Wajeeh, Muhammad Farid Johan, Wan Rohani Wan Taib, Imilia Ismail, and Hamid Ali Nagi Al-Jamal. 2023. "Thymoquinone Enhances Apoptosis of K562 Chronic Myeloid Leukemia Cells through Hypomethylation of SHP-1 and Inhibition of JAK/STAT Signaling Pathway" Pharmaceuticals 16, no. 6: 884. https://doi.org/10.3390/ph16060884

Al-Rawashde, F. A., Al-Sanabra, O. M., Alqaraleh, M., Jaradat, A. Q., Al-Wajeeh, A. S., Johan, M. F., Wan Taib, W. R., Ismail, I., & Al-Jamal, H. A. N. (2023). Thymoquinone Enhances Apoptosis of K562 Chronic Myeloid Leukemia Cells through Hypomethylation of SHP-1 and Inhibition of JAK/STAT Signaling Pathway. Pharmaceuticals, 16(6), 884. https://doi.org/10.3390/ph16060884